Canada· CA-DIN-02530333
JAMP POSACONAZOLE
A posaconazole product containing posaconazole, registered in Canada by JAMP PHARMA CORPORATION. The same ATC class is registered in 18 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Posaconazole is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AC04 (posaconazole), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 10 of them publish a price we can compare per daily dose
Posaconazole · ATC J02AC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of posaconazole costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $6.09 in United States to $82.67 in Italy — a ×14 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Posaconazole · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$82.67
- CH Switzerland$74.94
- US United States$6.09 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- POSACONAZOLE
- Manufacturer
- JAMP PHARMA CORPORATION
- Country
- Canada (CA)
- ATC code
- J02AC04
- ATC class
- Posaconazole
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for posaconazole.
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Posaconazole · interactions on record
415 records
- 143 severe
- 219 moderate
- 7 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Posaconazole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNoxafil 40mg/ml oral suspensionMerck Sharp & Dohme (UK) Ltd
- CzechiaGUDIVINEgis Pharmaceuticals PLC, Budapešť
- United StatesNOXAFILMerck Sharp & Dohme LLC
- NetherlandsNoxafil 100 mg maagsapresistente tablettenMerck Sharp & Dohme B.V.
- GermanyOssmiqHexal Ag
- PolandNoxafilMerck Sharp & Dohme B.V.
- SpainNOXAFIL 100 MG COMPRIMIDOS GASTRORRESISTENTESMerck Sharp & Dohme B.V.
- SwitzerlandNoxafil 100 mg, magensaftresistente TabletteMSD Merck Sharp & Dohme AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Posaconazol Altan, Posaconazol Ratiopharm
- Belgium · Posaconazol Ab, Posaconazol Sandoz
- Czechia · Gudivin, Posaconazole Accord
- Germany · Ossmiq, Posaconazol
- Denmark · Posaconazol Stada, Posaconazol Teva B.V.
- Estonia · Ossmiq, Posaconazol
- Spain · Posaconazol, Posaconazol Abdi
- Finland · Posaconazol Vivanta, Posaconazole
- France · Posaconazole Accord, Posaconazole Altan
- United Kingdom (Northern Ireland) · Posaconazol Msn Laboratories, Posaconazole
- Greece · Posaconazole Genepharm, Posaconazole Stada
- Croatia · Posakonazol Abdi, Posakonazol Msn
- Hungary · Gudivin, Posaconazol Accord
- Ireland · Posaconazole, Posaconazole Teva
- Iceland · Noxafil, Posaconazole Accord
- Italy · Posaconazole Eg Stada, Posaconazole Mylan
- Liechtenstein · Noxafil, Posaconazole Accord
- Lithuania · Posaconazole Stada
- Latvia · Posaconazole Stada
- Malta · Posaconazole, Posaconazole Anfarm
- Netherlands · Posaconazol 100 Mg, Posaconazol Abdi
- Norway · Noxafil, Posaconazole Accord
- Poland · Posaconazole Accord, Posaconazole Aurovitas
- Portugal · Posaconazol Almovar, Posaconazol Anfarm
- Romania · Posaconazol, Posaconazol Accord
- Sweden · Posaconazole, Posaconazole Amarox
- Slovenia · Posaconazol Msn, Posakonazol Stada
- Slovakia · Posaconazol Msn, Posaconazole Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c6f3ee9-a780-41ca-a38f-249da9b8218a GET /v1/drugs/5c6f3ee9-a780-41ca-a38f-249da9b8218a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02530333",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J02AC04",
"schedule": [
"Prescription"
],
"drug_code": "101953",
"strengths": [
"40 MG"
],
"ahfs_class": null,
"substances": [
"POSACONAZOLE"
],
"product_categorization": null
}See everything about posaconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.